Y. Sun, Y. Wu, and Y. Zheng, “Role of Tepotinib, Capmatinib and Crizotinib in non-small cell lung cancer”, HSET, vol. 6, pp. 321–327, Jul. 2022, doi: 10.54097/hset.v6i.976.